Related Experiment Video
Updated: Dec 29, 2025
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications
Bruce D Leckey1, M Angelica Selim1, Rami N Al-Rohil1
1Division of Dermatopathology, Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Abstract:
SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently recognized entity with undifferentiated rhabdoid morphology and mutations in the switch/sucrose nonfermenting BRG1-associated factors complex. Patients are typically males in their fifth decade with a history of smoking who present with rapidly progressive intrathoracic disease and follow an aggressive clinical course. Metastatic disease is reported in up to 77% of cases; however, to our knowledge, cutaneous metastasis has not been reported nor has it been reported as the initial manifestation of the disease. Recognizing SMARCA4-DTS from other types of epithelioid tumors that involve the skin is clinically relevant, as targeted therapies for SMARC-deficient tumors are currently being investigated and early clinical trial data show therapeutic benefit.
Insights
SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a rare cancer. This study highlights a new finding: skin metastasis of SMARCA4-DTS, which has not been previously documented.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a rare, aggressive cancer.
- It is characterized by undifferentiated rhabdoid morphology and mutations in the SWI/SNF complex.
- Patients are typically middle-aged males with a history of smoking presenting with advanced intrathoracic disease.
Observation:
- Metastatic disease is common in SMARCA4-DTS, occurring in up to 77% of cases.
- Cutaneous metastasis has not been previously reported in SMARCA4-DTS.
- This is the first report of skin metastasis as an initial manifestation of the disease.
Findings:
- SMARCA4-DTS can present with cutaneous metastases.
- This presentation mimics other epithelioid skin tumors, posing a diagnostic challenge.
- Early recognition is crucial for appropriate management.
Implications:
- Identifying SMARCA4-DTS skin metastases is clinically significant.
- Targeted therapies for SMARCA-deficient tumors are under investigation.
- Early clinical data suggest potential therapeutic benefits from these targeted treatments.
More Related Videos
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012